节点文献

血清首氨酰脯氨酸二肽氨基肽酶同工酶对原发性肝癌的诊断价值

The value of serum GPDA-F for the diagnosis of primary hepatocellular carcinoma

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 李梅倪润洲黄介飞肖明兵张弘魏群江枫孟宪镐

【Author】 LI Mei; NI Runzhou; HUANGJiefei; et al. (Department of Gastroenterology, Affiliated Hospital of Nantong Medical College, Nantong, Jiangsu Province, 226001, China)

【机构】 南通医学院附属医院消化内科!南通市226001南通医学院附属?

【摘要】 目的研究血清甘氨酰脯氨酸二肽氨基肽酶(glycylproline dipeptidyl aminopeptidase,GPDA)同工酶对PHC的诊断价值,提高早期 PHC和 AFP阴性PHC诊断水平。方法采用阶段梯度垂直平板聚丙烯酰胺凝胶电泳法进行血清GPDA同工酶分离检测,同步测定比较PHC患者血清GPDA同工酶与GPDA,Q.活性(TGPD)、AFP、肿瘤大小及ALT的关系。结果血清GPDA按其泳动速度可分为快带(GPDA-F)与慢带(GPDA-S)两种同工酶。PHC患者血清GPDA-F的阳性率为85.3%,而肝外肿瘤、转移性肝癌、肝炎后肝硬化、慢性肝炎中阳性率均较低,正常对照组以及良性肝占位全部阴性。GPDA-F阳性率在TGPDA活性增高组明显高于正常组(94.4%对750%),GPDA-F与AFP及肿瘤大小无关系。良性肝病ALT升高组GPDA-F阳性率高于ALT正常组,而PHC患者GPDA-F与ALT无关。PHC患者GPDA-F呈持续阳性,良性肝病患者GPDA-F常为一过性阳性。结论GPDA-F为一新的PHC血清标志物,有助于PHC的定性诊断,尤其对早期PHC及AFP阴性PHC的诊断具有重要价值。

【Abstract】 Objective To investigate the role of glycylproline dipeptidyl aminopeptidase isoenzymes in the diag- nosis of primary hepatocellular carcinoma (PHC). Methods We developed a stage gradient polyacrylamide gel electro- phoresis system to separate serum GPDA isoenzymes. Total GPDA activities, alpha-fetoprotein, the sizes of tumors and alanine aminotransferase (ALT) activities were also measured simultaneously and the correlation between GPDA-F and these indices was analyzed. Results Serum GPDA was separated into two bands, namely fast band (GPDA-F) and slow band (GPDA-S). GPDA-F was negative in all healthy persons as well as in the patients with benign liver filling defects, while it was positive in 85.3% cases of PHC. Liver cirrhosis, chronic hepatitis, extrahepatic carcinoma and metastatic liver carci- noma had low positive rates. GPDA-F was positively correlated with serum total GPDA activities, but had no correlation with AFP and size of the tumors. There was the correlation between GPDA-F and ALT in benign liver diseases, but no correlation between GPDA-F and ALT in PHC. Serial measurements of serum GPDA-F showed that GPDA-F was persistently positive in PHC but might change into negative in benign liver diseases. Dynamic determination of GPDA-F might be helpful to differentiate true positive of PHC from false positive of benign liver diseases. Conclusion GPDA-F is a new serum marker of PHC. Measurement of serum GPDA-F is of value for the diagnosis of PHC, especially for those at early stage or with negative AFP.

【基金】 国家教育委员会留学回国人员科研经费(1995)!806
  • 【文献出处】 中华肝脏病杂志 ,CHINESE JOURNAL OF HEPATOLOGY , 编辑部邮箱 ,2000年03期
  • 【分类号】R735.7
  • 【被引频次】8
  • 【下载频次】37
节点文献中: 

本文链接的文献网络图示:

本文的引文网络